Axeq announces Turnkey Discovery sequencing and analysis services

Axeq Technologies announced the industry-first Axeq Turnkey Discovery analytical bioinformatic services coupled with high-coverage exome sequencing applications. The fully-integrated sequencing and analysis services enable researchers to perform exome sequencing and determine putative genetic variant candidates within a few weeks. The Turnkey Discovery processes are categorized into specific modules, and are applicable to a variety of research designs including samples from trios, sib pairs, extended families, and case-control studies.

The Axeq Turnkey Discovery services provide -

  • Data filtering, mapping and removal of poor quality variants
  • Sequential filtering of variants, based on clients' definitions, with extensive annotations
  • Comparisons of genetic variants among affected individuals and controls
  • Determination of putative candidates
  • Sanger sequencing services for further candidate validation at very competitive pricing

Introductory Package

Axeq also announced an introductory package priced at US$9,000. This integrated service package includes: exome sequencing of three samples of a trio family (two parents and one affected child) at 75-fold coverage; application of the complete Axeq Turnkey Discovery bioinformatic analysis to the resultant exome sequence data; and the delivery of a list of putative and robust candidates.

"The comprehensive Turnkey Discovery services present medical researchers, often with limited bioinformatics expertise, the exciting opportunity to complete projects, from patient samples to initial discovery, in a matter of just a few weeks," said Daniel Siu, Executive Vice President of Axeq. "The $9,000 introductory package makes the services even more affordable to many investigators with small budgets"

Source:

Axeq Technology

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Smoking linked to increased genetic mutations in myelodysplastic syndromes